Development of therapies for overcoming EMT-associated irreversible tyrosine kinase inhibitor resistance in EGFR lung cancer
Development of therapies for overcoming EMT-associated irreversible tyrosine kinase inhibitor resistance in EGFR lung cancer
批准号:
26860603
负责人:
Fukuda Koji
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2014
资助国家:
日本
项目状态:
已结题
起止时间:
2014-04-01 至 2016-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
HDAC inhibition overcomes crizotinib-resistance by inducing mesenchymal-epithelial reverting transition (MERT) via miR-200c up-regulation in EML4-ALK lung cancer cells.
HDAC 抑制通过 EML4-ALK 肺癌细胞中 miR-200c 上调诱导间充质上皮回复转变 (MERT) 来克服克唑替尼耐药。
DOI:
--
发表时间:
2016
期刊:
影响因子:
--
作者:
[Koji Fukuda, Shigeki Nanjo, Shinji Takeuchi, Tadaaki Yamada, Ryohei Katayama, Kengo Takeuchi, Hiroshi Nishihara, Seiji Yano.]
通讯作者:
Seiji Yano.
Susceptibility of cyclin-dependent kinase inhibitor 1 deficient mice to joint destruction of rheumatoid arthritis
-
批准号:20K17998
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.66万
-
财政年份:2020
-
负责人:Fukuda Koji
-
依托单位:
Development of treatment to overcome TKI resistance caused by EMT in lung cancer
-
批准号:18K07261
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2018
-
负责人:Fukuda Koji
-
依托单位:
Time Bank governance in community comprehensive care in super aged society
-
批准号:18K01450
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2018
-
负责人:Fukuda Koji
-
依托单位:
Development of ALK-TKI-resistant treatment due to EMT of ALK lung cancer
-
批准号:16K19447
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2016
-
负责人:Fukuda Koji
-
依托单位:
Comparative analysis on Growth and Innovation Policy processes in the EU and Japan
-
批准号:15K03296
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2015
-
负责人:Fukuda Koji
-
依托单位:
海外基金